Abstract

Renal denervation is being used as a blood pressure lowering therapy for patients with apparent treatment resistant hypertension. However, this population does not represent a distinct disease condition in which benefit is predictable. In fact, the wide range in effectiveness of renal denervation could be a consequence of this heterogeneous pathogenesis of hypertension. Since renal denervation aims at disrupting sympathetic nerves surrounding the renal arteries, it seems obvious to focus on patients with increased afferent and/or efferent renal sympathetic nerve activity. In this review will be argued, from both a pathophysiological and a clinical point of view, that chronic kidney disease is particularly suited to renal denervation.

Highlights

  • Renal denervation (RDN) is an invasive procedure in which a catheter is percutaneously introduced into the renal arteries

  • When applying RDN, the assumption is that renal sympathetic nerves are too active and that this activity is the main contributor to hypertension in these patients

  • In an earlier study we found a positive relationship between muscle sympathetic nerve activity (MSNA) levels and blood pressure (Siddiqi et al, 2009)

Read more

Summary

Chronic Kidney Disease As a Potential Indication for Renal Denervation

Renal denervation is being used as a blood pressure lowering therapy for patients with apparent treatment resistant hypertension. This population does not represent a distinct disease condition in which benefit is predictable. The wide range in effectiveness of renal denervation could be a consequence of this heterogeneous pathogenesis of hypertension. Since renal denervation aims at disrupting sympathetic nerves surrounding the renal arteries, it seems obvious to focus on patients with increased afferent and/or efferent renal sympathetic nerve activity. In this review will be argued, from both a pathophysiological and a clinical point of view, that chronic kidney disease is suited to renal denervation

INTRODUCTION
RENAL DENERVATION IN PATIENTS WITH CKD AND HYPERTENSION
Unmet Need in CKD from a Clinical Point of View
Rationale from a Pathophysiological Point of View
LOWERING SYMPATHETIC NERVE ACTIVITY
EFFECTS OF RDN IN CKD PATIENTS AND IN EXPERIMENTAL STUDIES
Findings
SUMMARY AND CONCLUSIONS
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call